Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1994 | 1 |
2003 | 1 |
2010 | 2 |
2021 | 2 |
2022 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798037
Clinical Trial.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group.
Peyrin-Biroulet L, et al.
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798039
Free article.
Clinical Trial.
Item in Clipboard
Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.
Lichtenstein GR, Thomsen OØ, Schreiber S, Lawrance IC, Hanauer SB, Bloomfield R, Sandborn WJ; Precise 3 Study Investigators.
Lichtenstein GR, et al.
Clin Gastroenterol Hepatol. 2010 Jul;8(7):600-9. doi: 10.1016/j.cgh.2010.01.014. Epub 2010 Feb 1.
Clin Gastroenterol Hepatol. 2010.
PMID: 20117244
Clinical Trial.
Item in Clipboard
Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.
Schreiber S, Colombel JF, Bloomfield R, Nikolaus S, Schölmerich J, Panés J, Sandborn WJ; PRECiSE 2 Study Investigators.
Schreiber S, et al.
Am J Gastroenterol. 2010 Jul;105(7):1574-82. doi: 10.1038/ajg.2010.78. Epub 2010 Mar 16.
Am J Gastroenterol. 2010.
PMID: 20234346
Clinical Trial.
Item in Clipboard
[Comparison of the effectiveness and tolerability of the saccharosum-sennosid-B solution and sodium-picosulfate in preparation for colonoscopy. Prospective, multicenter, randomized study].
Demeter P, Ujszászy L, Sike R, Tóth GT, Grenda A, Kiss GG, Novák J, Gurzó Z, Csiki Z.
Demeter P, et al. Among authors: gurzo z.
Orv Hetil. 2003 Aug 10;144(32):1587-90.
Orv Hetil. 2003.
PMID: 12974184
Clinical Trial.
Hungarian.
Item in Clipboard
[Rare late complication of transcystic drainage].
Novák J, Ottlakán A, Pásztor P, Gurzó Z, Kovács J, Libor J.
Novák J, et al. Among authors: gurzo z.
Orv Hetil. 1994 Nov 27;135(48):2651-3.
Orv Hetil. 1994.
PMID: 7808740
Hungarian.
Item in Clipboard
Cite
Cite